Haddad, Rita El
Matta, Joane
Lemogne, Cédric
Melchior, Maria
Zins, Marie
Airagnes, Guillaume
Funding for this research was provided by:
Caisse Nationale d’Assurance Maladie (not available)
Agence nationale de la recherche (ANR-11-INBS-0002)
L’Oréal (not available)
MSD (not available)
AstraZeneca Schweiz (not available)
Lundbeck (not available)
Article History
Received: 24 August 2021
Accepted: 22 August 2022
First Online: 2 September 2022
Declarations
:
: Guillaume Airagnes has received speakers and/or consulting fees from Pfizer, Lundbeck and Pierre Fabre. Cédric Lemogne has received speakers and/or consulting fees from Lundbeck, Boehringer Ingelheim, Janssen and Otsuka Pharmaceutical. However, it did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Rita El Haddad, Joane Matta, Maria Melchior and Marie Zins report no conflicts of interest.
: The CONSTANCES cohort has obtained the authorization of the National Data Protection Authority (Commission Nationale de l’Informatique et des Libertés, no. 910486) and was approved by the Institutional Review Board of the National Institute for Medical Research—INSERM (no. 01-011).
: All the participants have provided a written informed consent.
: All the participants have provided a written informed consent.